- Previous close
410.03 - Open
405.57 - Bid 395.00 x 1000
- Ask 395.00 x 1000
- Day's range
394.12 - 408.51 - 52-week range
220.55 - 417.14 - Volume
1,944,377 - Avg. Volume
1,104,618 - Market cap (intra-day)
105.818B - Beta (5Y monthly) 1.68
- PE ratio (TTM)
18.73 - EPS (TTM)
21.30 - Earnings date 25 Oct 2024
- Forward dividend & yield 2.64 (0.66%)
- Ex-dividend date 16 Sept 2024
- 1y target est
413.32
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
www.hcahealthcare.com220,000
Full-time employees
31 December
Fiscal year ends
Healthcare
Sector
Medical Care Facilities
Industry
Recent news: HCA
View more
Performance overview: HCA
Trailing total returns as of 24/10/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: HCA
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: HCA
View moreValuation measures
Market cap
102.95B
Enterprise value
144.89B
Trailing P/E
18.73
Forward P/E
15.90
PEG ratio (5-yr expected)
1.20
Price/sales (ttm)
1.57
Price/book (mrq)
--
Enterprise value/revenue
2.12
Enterprise value/EBITDA
10.64
Financial highlights
Profitability and income statement
Profit margin
8.40%
Return on assets (ttm)
11.47%
Return on equity (ttm)
736.11%
Revenue (ttm)
68.35B
Net income avi to common (ttm)
5.74B
Diluted EPS (ttm)
21.30
Balance sheet and cash flow
Total cash (mrq)
918M
Total debt/equity (mrq)
3,194.47%
Levered free cash flow (ttm)
3.2B